Gómez DM, Enciso OC, Vicuña M, Ojeda E, Ramos C, Vélez J, Ríos C

Language: Spanish
References: 22
Page: 106-112
PDF size: 191.70 Kb.

ABSTRACT

Introduction: Neuromuscular disorders in critically ill patients are entities that undertake the clinical course, prolong hospital stay, can lead to prolonged disability, the incidence is 50% or more.
Objective: To determine the frequency of polyneuropathy and myopathy in critically ill patients.
Material and methods: A descriptive case series type. Patients with mechanical ventilation > 10 days hospitalized in the ICU, without prior diagnosis suggestive of neuromuscular disease. Demographic characterization, risk factors and the correlation is described. Neuromuscular biopsy who died.
Results: Cent patients were enrolled. Main demographic characteristics: mean age (years) 55.8, 47% female gender and 53% male, 37% admission diagnoses sepsis, cardiovascular disease 13%, 10% TCE, 19.07 average hospital stay, days of mechanical ventilation 17. The frequency changes for electrophysiological study 90%, 79% by physical examination. Kappa coefficient (physical examination and electrophysiological study) with a value 0.0075 (p= 0.532) was performed for groups distribution coefficient matching laminate, which showed that despite the existence of different consistency time interval measured is low. Sixty two had sepsis or multiple organ failure. Four patients died neuromuscular biopsy was positive for myopathic commitment at all.
Conclusions: The frequency of neuromuscular pathology in ICU is high in our population, to associate physical examination and neurophysiological. Sepsis and multiple organ failure may be determinants of disease development.

REFERENCES

1. Kane SL, Dasta JF. Clinical outcomes of critical illness polyneuropathy. Pharmacotherapy. 2002;22(3):373-379.

2. van Mook WN, Hulsewe-Evers RP. Critical illness polyneuropathy. Curr Opin Crit Care. 2002;8(4):302-310.

3. de Seze M, Petit H, Wiart L, Cardinaud JP, Gaujard E, Joseph PA, et al. Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. Eur Neurol. 2000;43(2):61-69.

4. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33(11):1876-1891.

5. Witt NJ, Zochodne DW, Bolton CF, Grand’Maison F, Wells G, Young GB, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest. 1991;99(1):176-184.

6. Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 2000;26(9):1360-1363.

7. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001;27(8):1288-96.

8. Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol. 2005;252(3):343-51.

9. De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004;30(6):1117-1121.

10. Lacomis D. Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve. 2013;47(3):452-463.

11. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 1986;49(5):563-573.

12. Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve. 2000;23(12):1785-8.

13. Koch S, Spuler S, Deja M, Bierbrauer J, Dimroth A, Behse F, et al. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry. 2011;82(3):287-293.

14. Leijten FS, Harinck-de Weerd JE, Poortvliet DC, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 1995;274(15):1221-5.

15. Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med. 1997;23(11):1144-9.

16. Geller TJ, Kaiboriboon K, Fenton GA, Hayat GR. Vecuronium-associated axonal motor neuropathy:a variant of critical illness polyneuropathy? Neuromuscul Disord. 2001;11(6-7):579-582.

17. Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, et al. Critical illness myopathy and neuropathy. Lancet. 1996;347(9015):1579-82.

18. Visser LH. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol. 2006;13(11):1203-12.

19. Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31(4):1012-6.

20. Kerbaul F, Brousse M, Collart F, Pellissier JF, Planche D, Fernandez C, et al. Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit Care. 2004;8(6):R358-66.

21. Coakley JH, Nagendran K, Honavar M, Hinds CJ. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med. 1993;19(6):323-8.

22. Leijten FS, De Weerd AW, Poortvliet DC, De Ridder VA, Ulrich C, Harink-De Weerd JE. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med. 1996;22(9):856-61.